The efficacy of Tripterygium Glycosides in the treatment of Chinese patients with thyroid-associated orbitopathy: A systematic review and meta-analysis

Author:

Li Mingzhe,Wei BingchenORCID,Gao Tianshu,Gao Chenghan

Abstract

AbstractObjectiveThis study aims to conduct a systematic review of the effectiveness and safety of Tripterygium Glycosides interventions in the treatment of Chinese patients with thyroid-associated orbitopathy (TAO).MethodsA literature search was conducted using PubMed for English sources, and the CNKI, Chinese Biomedical Database, Wanfang Database, and VIP Database for Chinese sources. The search period extended from the beginning of the databases’ creation to Dec. 2023. The keywords used in the search were hyperthyroidism, thyroid-related immune orbitopathy (TRIO), ophthalmopathy, and Tripterygium Glycosides. Various combinations of search terms were used, depending on the database being queried. All the trials included in the study were clinical randomized controlled trials (RCTs).Results33 RCTs or quasi-RCTs that met the inclusion criteria were included. The meta-analysis included 27 RCTs. 6 RCTs were excluded from the analysis due to the absence of a control group, but they were still included in the systematic review. 27 RCTs or quasi-RCTs involving 2,134 patients were included in the meta-analysis. The TRIO patients in the treatment group received Tripterygium Glycosides in combination with Thiamazole, Prednisone, Levothyroxine sodium, or a combination of these medications. While the TRIO patients in the control group were treated with Thiamazole, Prednisone, Levothyroxine sodium, or a combination of these treatments, the meta-analysis results show that the overall effectiveness rate of the treatment group and the control group wasP= 0.05, I2= 0.33 < 0.5 [MD = 4.45, 95% CI (3.31, 5.99),P< 0. 00001]. The former was significantly superior to the latter. At the same time, a risk assessment was conducted for the study of the 2 groups. The former was significantly superior to the latter. Furthermore, the clinical effectiveness rate of eyeball prominence wasP< 0. 00001, I2= 0.98 > 0.5 [MD = 2.40, 95% CI (2.28, 2.51),P< 0. 00001]. The clinical effectiveness rate of CAS score wasP< 0. 00001, I2= 0.89 > 0.5 [MD = 1.68, 95% CI (1.50, 1.85),P< 0. 00001]. The clinical effectiveness rate of FT3wasP< 0. 00001, I2= 0.98 > 0.5 [MD = 0.95, 95% CI (0.81, 1.08),P< 0. 00001], the clinical effectiveness rate of FT4wasP< 0. 00001, I2= 0.95 > 0.5 [MD = 2.12, 95% CI (1.99, 2.25),P< 0. 00001], and the clinical effectiveness rate of TSH wasP< 0. 00001, I2= 0.89 > 0.5 [MD = −0.19, 95% CI (−0.21, −0.17),P< 0. 00001].ConclusionThe experience with the treatment of TAO using Tripterygium Glycosides was promising. The existing evidence suggests that treatment with Tripterygium Glycosides may be more effective in enhancing the response rate, quality of life, and FT3levels compared to treatment with Prednisone, Levothyroxine sodium, and/or Thiamazole alone.

Publisher

Cold Spring Harbor Laboratory

Reference60 articles.

1. Progress of Chinese medicine in treating hyperthyroid exophthalmos;Journal of Traditional Chinese Medicine,2009

2. Tripterygium Glycosides with tapazole and prednisone in the treatment of hyperthyroidism exophthalmos;Journal of Medical Forum,2010

3. In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidyl bine;European Journal of Pharmaceutics and Bio pharmaceutics,2010

4. Clinical observation of 50 cases of children with purpura nephritis treated with Tripterygium Glycosides tablets;Jiangsu Medical Journal,1987

5. Ministry of health of the people’s Liberation Army General Logistics Department. Diagnosis of clinical diseases based on the improvement of the standard. Beijing: People’s military medical press. 1198–1991(1987).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3